SE8901660L - Anvaendning av gonadoliberinderivat foer fram- staellning av tumoerinhiberande farmaceutiska kompositioner - Google Patents

Anvaendning av gonadoliberinderivat foer fram- staellning av tumoerinhiberande farmaceutiska kompositioner

Info

Publication number
SE8901660L
SE8901660L SE8901660A SE8901660A SE8901660L SE 8901660 L SE8901660 L SE 8901660L SE 8901660 A SE8901660 A SE 8901660A SE 8901660 A SE8901660 A SE 8901660A SE 8901660 L SE8901660 L SE 8901660L
Authority
SE
Sweden
Prior art keywords
group
stands
4alkyl
glycyl
pharmaceutical compositions
Prior art date
Application number
SE8901660A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8901660D0 (sv
Inventor
Ri G K
Original Assignee
Innofinance Altalanos Innovaci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innofinance Altalanos Innovaci filed Critical Innofinance Altalanos Innovaci
Publication of SE8901660D0 publication Critical patent/SE8901660D0/xx
Publication of SE8901660L publication Critical patent/SE8901660L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
SE8901660A 1988-05-10 1989-05-10 Anvaendning av gonadoliberinderivat foer fram- staellning av tumoerinhiberande farmaceutiska kompositioner SE8901660L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU882347A HU199694B (en) 1988-05-10 1988-05-10 Process for producing citostatic pharmaceutical compositions containing gonadoliberin derivatives

Publications (2)

Publication Number Publication Date
SE8901660D0 SE8901660D0 (sv) 1989-05-10
SE8901660L true SE8901660L (sv) 1989-11-11

Family

ID=10958948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901660A SE8901660L (sv) 1988-05-10 1989-05-10 Anvaendning av gonadoliberinderivat foer fram- staellning av tumoerinhiberande farmaceutiska kompositioner

Country Status (16)

Country Link
JP (1) JPH0215097A (fr)
KR (1) KR900017610A (fr)
BE (1) BE1004932A3 (fr)
CH (1) CH678013A5 (fr)
DE (1) DE3915317A1 (fr)
DK (1) DK228289A (fr)
FI (1) FI892275A7 (fr)
FR (1) FR2631237A1 (fr)
GB (1) GB2218335B (fr)
GR (1) GR890100315A (fr)
HU (1) HU199694B (fr)
IL (1) IL89998A0 (fr)
IT (1) IT1229251B (fr)
LU (1) LU87516A1 (fr)
NL (1) NL8901159A (fr)
SE (1) SE8901660L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760000A (en) * 1994-05-13 1998-06-02 University Technologies International,Inc. Inhibition of liver cancer by the use of GnRH and GnRH analogs
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
HU189394B (en) * 1983-12-23 1986-06-30 Koezponti Valto- Es Hitelbank Rt Innovacios Alap,Hu Method for producing spermatozoa suitable for fertilization from mature fishes
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
WO1986001105A1 (fr) * 1984-08-02 1986-02-27 Fernand Labrie Composition pharmaceutique pour le traitement de cancers dependant d'hormones
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4721775A (en) * 1985-08-26 1988-01-26 Board Of Regents, The University Of Texas System Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids
HU194913B (en) * 1986-01-03 1988-03-28 Innofinance Altalanos Innovaci Process for producing novel gonadoliberin derivatives containing in the sixth position aromatic amino carboxylic acid and medical preparations containing these compounds

Also Published As

Publication number Publication date
HU199694B (en) 1990-03-28
IT1229251B (it) 1991-07-26
GB2218335A (en) 1989-11-15
FI892275A0 (fi) 1989-05-10
SE8901660D0 (sv) 1989-05-10
GB8910724D0 (en) 1989-06-28
JPH0215097A (ja) 1990-01-18
HUT49813A (en) 1989-11-28
NL8901159A (nl) 1989-12-01
BE1004932A3 (fr) 1993-03-02
KR900017610A (ko) 1990-12-19
IL89998A0 (en) 1989-12-15
CH678013A5 (fr) 1991-07-31
DK228289D0 (da) 1989-05-10
IT8920435A0 (it) 1989-05-11
GB2218335B (en) 1991-09-25
FR2631237A1 (fr) 1989-11-17
GR890100315A (el) 1990-03-12
FI892275A7 (fi) 1989-11-11
DE3915317A1 (de) 1989-11-23
LU87516A1 (fr) 1990-12-11
DK228289A (da) 1989-11-11

Similar Documents

Publication Publication Date Title
BG103335A (en) Application of fumaric acid derivatives
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
BR9815159A (pt) Preparação de conjugados de polietileno glicol-grf especìfica ao sìtio
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
ES2164663T3 (es) Derivados de paclitaxel unidos a polimeros.
ATE513847T1 (de) Bioaktive peptide
KR900002801A (ko) 당뇨병 치료용 약학적제제
ES2107470T3 (es) Producto que contiene factor de crecimiento y glutamina y uso del factor de crecimiento para el tratamiento de la mucosa intestinal.
AU2001264515A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
ES2193272T3 (es) Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen.
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
AU7683296A (en) Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
CY1106108T1 (el) Πεπτιδια και/ή πρωτεϊνες καθως και χρησιμοποιηση των ιδιων για την παρασκευη ενος θepαπευτικου και/ή προληπτικου φαρμακου
BR9809103A (pt) Forma farmacêutica estável de administração para peptìdeos, proteìnas e ácidos nucléicos
SE8901660D0 (sv) Anvaendning av gonadoliberinderivat foer fram- staellning av tumoerinhiberande farmaceutiska kompositioner
KR930017885A (ko) 항종양 조성물 및 종양의 치료방법
KR920703003A (ko) 혈관활성 바소토신 유도체
SE8700016L (sv) Gonadoliberinderivat som innehaller en aromatisk aminokarboxylsyra i 6-stellning, farmaceutiska och veterinermedicinska kompositioner innehallande dem samt forfarande for framstellning av densamma
KR940021074A (ko) Vip, 또는 그의 유사체, 유도체 또는 단편으로 이루어지는 제약 조성물
EP0272684A3 (en) Derivatives of n-(methylsulphonylphenylethyl)-2-propenamides and their use as antibiotics
ES2184121T3 (es) Formulacion para el tratamiento y/o profilaxis de la demencia.
KR890009974A (ko) 신규 화합물들
DK628388D0 (da) Vincristinholdigt produkt
DE3882233D1 (de) Gefaessaktive peptide.
CY1106169T1 (el) Συνθεση αποτελουμενη απο προπιονυλ l-καρνιτινη και γλυκινη για την προληψη και/ή θepαπεια των κυτοτοξικων αποτελεσματων που διεγειρονται απο τη χρηση ανοσοκατασταλτικων παραγοντων

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8901660-4

Effective date: 19940527